AstraZeneca Says Klygefa Recommended For EU Approval To Treat Adults With Generalized Myasthenia Gravis
AZN•EU approval recommendation for Klygefa
Sept. 18 (Reuters) - AstraZeneca PLC AZN.L:
- AstraZeneca: Klygefa (gefurulimab) recommended for approval in the EU by CHMP for treatment of adults with generalised myasthenia gravis (gMG)
